Johnson & Johnson and alliance of competences "Park of active molecules" sign partnership agreement

Johnson & Johnson and Park of Active Molecules (PAM) have announced the execution of a partnership agreement between them.

Johnson & Johnson and alliance of competences "Park of active molecules" sign partnership agreement

Johnson & Johnson and Park of Active Molecules (PAM) have announced the execution of a partnership agreement between them. According to Johnson & Johnson's Press Office, the company is expanding its innovative activities in Russia and starts to cooperate with one of the most actively developing players of the Kaluga pharmaceutical cluster implementing projects in innovative biopharmaceutics.

The cooperation will require Johnson & Johnson to assess PAM's short-listed projects being at early development stages on whether they meet the most critical demands of the healthcare industry and to find solutions being of interest for the public, featuring innovative potential and being suitable for commercialization. The most interesting programmes will be illegible to become part of Johnson & Johnson's business incubator and develop based on the company's research centers.

Alliance of Competencies "Park of Active Molecules" (Obninsk) is an open system combining numerous competencies for implementing projects in innovative biopharmaceutics. PAM's residents and partners include manufacturing enterprises, research centers, investment companies and other entities, i.e. all organizations that directly or indirectly relate to innovative biopharmaceutics.